Molina Healthcare MOH Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $10.8B-3.1% | $11.38B+8.3% | $11.48B+11.0% | $11.43B+15.7% | $11.15B+12.2% | ||
| $9.27B-2.2% | $10.14B+12.6% | $10.04B+16.2% | $9.83B+17.5% | $9.48B+12.7% | ||
| $779M+0.6% | $795M+19.5% | $729M+7.8% | $711M+2.9% | $774M+8.9% | ||
| $10.71B0.0% | $11.54B+14.0% | $11.34B+14.9% | $11.05B+17.0% | $10.71B+12.7% | ||
| $83M-80.8% | —— | $137M-70.7% | $373M-14.1% | $433M+1.6% | ||
| 0.8%-3.1pp | —— | 1.2%-3.3pp | 3.3%-1.1pp | 3.9%-0.4pp | ||
| $54M+25.6% | $52M+52.9% | $49M+69.0% | $48M+71.4% | $43M+59.3% | ||
| $22M-4.3% | $24M+9.1% | $22M+10.0% | $22M+4.8% | $23M+4.5% | ||
| $29M-92.6% | —— | $88M-79.9% | $325M-20.0% | $390M-2.3% | ||
| $15M-83.7% | —— | $9M-92.0% | $70M-33.3% | $92M-6.1% | ||
| $14M-95.3% | —— | $79M-75.8% | $255M-15.3% | $298M-1.0% | ||
| 0.1%-2.5pp | —— | 0.7%-2.5pp | 2.2%-0.8pp | 2.7%-0.4pp | ||
| $0.27-95.0% | —— | $1.51-73.3% | $4.75-8.1% | $5.45+5.4% | ||
| $122M-74.6% | —— | $182M-64.6% | $431M-10.2% | $481M+2.1% | ||
| 1.1%-3.2pp | —— | 1.6%-3.4pp | 3.8%-1.1pp | 4.3%-0.4pp | ||
| $83M-80.8% | —— | $137M-70.7% | $373M-14.1% | $433M+1.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Molina Healthcare's revenue?
- Molina Healthcare (MOH) generated $45.1B in revenue over the trailing twelve months, up 7.7% year over year.
- Is Molina Healthcare profitable?
- Molina Healthcare reported $646.0M in net income over the trailing twelve months, a 2.0% net margin.
- What are Molina Healthcare's profit margins?
- Gross margin is 12.9% and operating margin is 3.0%, with a 2.0% net margin.
- What is Molina Healthcare's earnings per share?
- Molina Healthcare's diluted EPS over the trailing twelve months is $11.98.
- Where does Molina Healthcare's income statement data come from?
- Every line is extracted from Molina Healthcare's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
